WO2011029701A3 - Antibakterielle deodorantien und/oder antitranspirantien gegen körpergeruch - Google Patents

Antibakterielle deodorantien und/oder antitranspirantien gegen körpergeruch Download PDF

Info

Publication number
WO2011029701A3
WO2011029701A3 PCT/EP2010/061965 EP2010061965W WO2011029701A3 WO 2011029701 A3 WO2011029701 A3 WO 2011029701A3 EP 2010061965 W EP2010061965 W EP 2010061965W WO 2011029701 A3 WO2011029701 A3 WO 2011029701A3
Authority
WO
WIPO (PCT)
Prior art keywords
staphylococcus
cosmetic
deodorising
pharmaceutical compositions
corynebacterium
Prior art date
Application number
PCT/EP2010/061965
Other languages
English (en)
French (fr)
Other versions
WO2011029701A2 (de
Inventor
Bernhard Banowski
Rainer Simmering
Original Assignee
Henkel Ag & Co. Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Ag & Co. Kgaa filed Critical Henkel Ag & Co. Kgaa
Publication of WO2011029701A2 publication Critical patent/WO2011029701A2/de
Publication of WO2011029701A3 publication Critical patent/WO2011029701A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/28—Zirconium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cosmetics (AREA)

Abstract

Bestimmte Bakteriophagen eignen sich zur Einarbeitung in bestimmte Antitranspirant- und Deodorant-Zusammensetzungen und bekämpfen dort die Geruch verursachenden Bakterien wirksam und spezifisch ohne die Haut zu reizen oder die hautpositiven Keime in der Hautflora zu schädigen. Entsprechende kosmetische oder pharmazeutische, zur Körperdeodorierung geeignete Zusammensetzungen enthalten in einem kosmetisch oder dermatologisch verträglichen Träger mindestens einen Deodorant- oder Antitranspirant-Wirkstoff und mindestens einen Vertreter aus der Gruppe der Bakteriophagen, die gegen mindestens einen der folgenden Keime wirksam sind: Staphylococcus aureus und/oder Staphylococcus hominis und/oder Corynebacterium tuberculostearicum und/oder Anaerococcus octavius und/oder Staphylococcus. Lugdunensis und/oder Finegoldia magna und/oder Corynebacterium amycolatum und/oder Corynebacterium afermentans und/oder Staphylococcus epidermidis und/oder Staphylococcus capitis und/oder Staphylococcus haemolyticus und/oder Propionibacterium avidum und/oder Corynebacterium kroppenstedtii und/oder Peptinophilus spec.
PCT/EP2010/061965 2009-09-14 2010-08-17 Antibakterielle kosmetische oder pharmazeutische, zur körperdeodorierung geeignete zusammensetzungen gegen körpergeruch WO2011029701A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102009029423A DE102009029423A1 (de) 2009-09-14 2009-09-14 Antibakterielle kosmetische oder pharmazeutische, zur Körperdeodorierung geeignete Zusammensetzungen gegen Körpergeruch
DE102009029423.6 2009-09-14

Publications (2)

Publication Number Publication Date
WO2011029701A2 WO2011029701A2 (de) 2011-03-17
WO2011029701A3 true WO2011029701A3 (de) 2013-05-16

Family

ID=43603112

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2010/061965 WO2011029701A2 (de) 2009-09-14 2010-08-17 Antibakterielle kosmetische oder pharmazeutische, zur körperdeodorierung geeignete zusammensetzungen gegen körpergeruch

Country Status (2)

Country Link
DE (1) DE102009029423A1 (de)
WO (1) WO2011029701A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11273187B2 (en) 2015-11-30 2022-03-15 Joseph E. Kovarik Method and system for reducing the likelihood of developing depression in an individual
US11419903B2 (en) 2015-11-30 2022-08-23 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US11191665B2 (en) 2011-02-04 2021-12-07 Joseph E. Kovarik Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US11523934B2 (en) 2011-02-04 2022-12-13 Seed Health, Inc. Method and system to facilitate the growth of desired bacteria in a human's mouth
US10940169B2 (en) 2015-11-30 2021-03-09 Joseph E. Kovarik Method for reducing the likelihood of developing cancer in an individual human being
US9987224B2 (en) 2011-02-04 2018-06-05 Joseph E. Kovarik Method and system for preventing migraine headaches, cluster headaches and dizziness
US10842834B2 (en) 2016-01-06 2020-11-24 Joseph E. Kovarik Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
US10245288B2 (en) 2011-02-04 2019-04-02 Joseph E. Kovarik Method and system for reducing the likelihood of developing NASH in an individual diagnosed with non-alcoholic fatty liver disease
US10512661B2 (en) 2011-02-04 2019-12-24 Joseph E. Kovarik Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
US10835560B2 (en) 2013-12-20 2020-11-17 Joseph E. Kovarik Reducing the likelihood of skin cancer in an individual human being
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US10010568B2 (en) 2011-02-04 2018-07-03 Katherine Rose Kovarik Method and system for reducing the likelihood of a spirochetes infection in a human being
US10687975B2 (en) 2011-02-04 2020-06-23 Joseph E. Kovarik Method and system to facilitate the growth of desired bacteria in a human's mouth
US10111913B2 (en) 2011-02-04 2018-10-30 Joseph E. Kovarik Method of reducing the likelihood of skin cancer in an individual human being
US10583033B2 (en) 2011-02-04 2020-03-10 Katherine Rose Kovarik Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
WO2013191363A1 (ko) * 2012-06-22 2013-12-27 주식회사 씨티씨바이오 신규한 박테리오파지 및 병원성 박테리아 증식 억제 용도
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US11529379B2 (en) 2013-12-20 2022-12-20 Seed Health, Inc. Method and system for reducing the likelihood of developing colorectal cancer in an individual human being
US11213552B2 (en) 2015-11-30 2022-01-04 Joseph E. Kovarik Method for treating an individual suffering from a chronic infectious disease and cancer
US11642382B2 (en) 2013-12-20 2023-05-09 Seed Health, Inc. Method for treating an individual suffering from bladder cancer
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US11672835B2 (en) 2013-12-20 2023-06-13 Seed Health, Inc. Method for treating individuals having cancer and who are receiving cancer immunotherapy
US11026982B2 (en) 2015-11-30 2021-06-08 Joseph E. Kovarik Method for reducing the likelihood of developing bladder or colorectal cancer in an individual human being
KR20200094178A (ko) * 2017-11-29 2020-08-06 액세스 비지니스 그룹 인터내셔날 엘엘씨 피부 마이크로바이옴의 변형을 위한 방법 및 국소 조성물
KR102334451B1 (ko) 2020-05-29 2021-12-03 코스맥스 주식회사 코리네박테리움 아페르멘탄스 균주 및 그의 피부 상태 개선 용도

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0414304A2 (de) * 1989-08-21 1991-02-27 Unilever N.V. Wässrige Zusammensetzung auf der Basis eines Tensids und eines Bacteriophagen
DE102004032734A1 (de) * 2004-03-18 2005-10-06 Henkel Kgaa Präbiotisch wirksame Substanzen für Deodorantien
WO2009101615A1 (en) * 2008-02-12 2009-08-20 Technion Research & Development Foundation Ltd. Methods and compositions for controlling body odor

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2571030A (en) 1950-03-15 1951-10-09 Reheis Company Inc Astringent, antiperspirant, and method of making
US3904741A (en) 1970-10-26 1975-09-09 Armour Pharma Alcohol soluble basic aluminum chlorides and method of making same
CA958338A (en) 1971-03-08 1974-11-26 Chung T. Shin Antiperspirant powder aerosol compositions containing aluminum chloride and water soluble aluminum compounds and methods of preparation
US3887692A (en) 1972-07-10 1975-06-03 Armour Pharma Microspherical basic aluminum halides and method of making same
US4017599A (en) 1973-11-23 1977-04-12 Armour Pharmaceutical Company Aluminum-zirconium anti-perspirant systems with salts of amino acids
DE2504381A1 (de) 1974-02-04 1975-12-18 Procter & Gamble Zirkonium- und hafniumsalze und ihre komplexe mit aluminiumverbindungen und aminosaeuren, verfahren zur herstellung dieser salze und komplexe sowie antiperspirationsmittel, die diese komplexe enthalten
US4359456A (en) 1976-01-14 1982-11-16 Lever Brothers Company Antiperspirant activity of basic aluminum compounds
GB2048229A (en) 1979-04-20 1980-12-10 Gillette Co Aluminium Chlorhydroxide and Preparation Thereof
US4775528A (en) 1983-08-16 1988-10-04 The Gillette Company Antiperspirant composition
US5643558A (en) 1994-11-02 1997-07-01 The Gillette Company Method of making polyhydric alcohol solutions of enhanced efficacy antiperspirant actives
GB2299506B (en) 1995-04-03 1999-04-14 Unilever Plc Antiperspirant actives and compositions
US6010688A (en) 1997-06-25 2000-01-04 The Gillette Company Polyhydric alcohol stabilized antiperspirant salt solutions
US6042816A (en) 1998-08-19 2000-03-28 The Gillette Company Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
DE19921183A1 (de) 1999-05-07 2000-11-09 Henkel Kgaa Mehrphasen-Antitranspirant-Stift
US6436381B1 (en) 2000-10-25 2002-08-20 The Gillette Company Aluminum-zirconium antiperspirant salts with high peak 5 al content
US6838032B2 (en) 2001-02-15 2005-01-04 The Gillette Company Methods of manufacturing personal care products
US6663854B1 (en) 2002-06-19 2003-12-16 Yan-Fei Shen Aluminum-zirconium antiperspirant salts made with zirconium salts having low Zr:Cl ratio
US6835373B2 (en) 2002-07-12 2004-12-28 The Procter & Gamble Company Non-irritating antiperspirant compositions containing acidic antiperspirant active
US6936242B2 (en) 2002-11-15 2005-08-30 The Gillette Company Multi-portion antiperspirant composition
US7105691B2 (en) 2003-06-26 2006-09-12 Colgate-Palmolive Company Aluminum / zirconium / glycine antiperspirant actives stabilized with Betaine
US6902723B2 (en) 2003-08-14 2005-06-07 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium
US6923952B2 (en) 2003-08-14 2005-08-02 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium or calcium

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0414304A2 (de) * 1989-08-21 1991-02-27 Unilever N.V. Wässrige Zusammensetzung auf der Basis eines Tensids und eines Bacteriophagen
DE102004032734A1 (de) * 2004-03-18 2005-10-06 Henkel Kgaa Präbiotisch wirksame Substanzen für Deodorantien
WO2009101615A1 (en) * 2008-02-12 2009-08-20 Technion Research & Development Foundation Ltd. Methods and compositions for controlling body odor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ARA K ET AL: "Foot odor due to microbial metabolism and its control", CANADIAN JOURNAL OF MICROBIOLOGY, NRC RESEARCH PRESS, CA, vol. 52, no. 4, 1 January 2006 (2006-01-01), pages 357 - 364, XP008126845, ISSN: 0008-4166 *

Also Published As

Publication number Publication date
WO2011029701A2 (de) 2011-03-17
DE102009029423A1 (de) 2011-03-24

Similar Documents

Publication Publication Date Title
WO2011029701A3 (de) Antibakterielle deodorantien und/oder antitranspirantien gegen körpergeruch
WO2011159071A3 (ko) 항균 또는 항염증 활성을 가지는 펩타이드 및 이를 유효성분으로 함유하는 약제학적 조성물
TW200716623A (en) Chemical compounds
MY146081A (en) Composition and method for pre-surgical skin disinfection
WO2013102021A3 (en) LOW pH DISINFECTANT COMPOSITION
HK1138735A1 (en) Disinfectant
WO2011128297A3 (en) Fungicidal combinations of dithiino - tetracarboxamide derivatives and microorganisms or isoflavones
WO2016108045A3 (en) Antimicrobial compounds, compositions and methods
MX2017004091A (es) Composicion y equipos para inhibicion de infeccion microbiana patogena y metodos para usar los mismos.
EP2279662A3 (de) 5,7.4'-trihydroxy-3',5'-dimethoxyflavon als antibakterielles Mittel
WO2007148919A8 (en) Bacteriophage having killing activity specific to staphylococcus aureus
WO2012008781A3 (ko) 2,5-다이케토피페라진 유도체를 활성성분으로 포함하는 농업용 약제
WO2010115184A3 (en) Hydroxythienoquinolones and related compounds as anti-infective agents
PH12014502824A1 (en) Nonwoven materials containing chlorhexidine acetate and triclosan
EP3216798A3 (de) Ketolidverbindungen
WO2008126846A1 (ja) バンコマイシン耐性グラム陽性細菌用抗菌剤
MX2021013853A (es) Uso de un azucar o alcohol de azucar.
TW200730579A (en) Antimicrobial plastics composition with low elution rate and with long period of activity
WO2008146172A3 (en) Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
WO2013041663A3 (de) Modifizierte apidaecinderivate als antibiotische peptide
WO2012054521A8 (en) Antimicrobial polyether and polyol compounds
WO2011023887A3 (fr) Utilisation d'une microemulsion pour lutter contre les poux
MX2015008373A (es) Peptidos antimicrobianos, composiciones que los comprende y usos.
PL2297195T3 (pl) Peptydy przeciwbakteryjne
WO2012131363A3 (en) Deodorant formulations

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10742847

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10742847

Country of ref document: EP

Kind code of ref document: A2